View Clinical Trial (Medical Research Study)
A Modified Version of Cognitive Processing Therapy for Treatment of Patients Diagnosed With Posttraumatic Stress Disorder (PTSD) and Alcohol Dependence or Alcohol Abuse - NCT00639288-06516(Clinical Trial 210094)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
West Haven |
|
State:
|
|
CT |
| Zip Code: |
|
06516 |
| Conditions: |
|
Alcohol Dependence - PTSD |
| Purpose: |
|
Objective: To evaluate the efficacy of a modified version of cognitive processing therapy -
cognitive (CPT-C) versus historical controls in reducing alcohol consumption and decreasing
symptoms of PTSD in patients with comorbid posttraumatic stress disorder (PTSD) and alcohol
dependence or alcohol abuse.
Hypothesis: We predict that CPT-C will significantly reduce the number of drinking days
(measured by the Timeline Follow Back Method [TLFB]) and reduce the symptoms of PTSD
(measured by the [CAPS and PCL] scores) compared to historical controls in patients with
alcohol dependence or alcohol abuse and PTSD.
Design: This is a 12-week outpatient intervention of modified CPT-C versus treatment as
usual in individuals with PTSD and alcohol dependence or alcohol abuse. Treatment consists
of weekly sessions lasting approximately 60 minutes.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
1. Males and females between the ages of 21-65 years old.
2. Current alcohol dependence or alcohol abuse, as determined by the Structured Clinical
Interview for DSM-IV Axis I Disorder (SCID; First et al. 1996). Not requiring
detoxification from alcohol and able to remain abstinent for 3 days prior to
treatment, and the stated goal of study is abstinence. Abstinence no more than past
29 days. Primary substance dependence diagnosis of alcohol dependence or alcohol
abuse.
3. Current PTSD as determined by the Clinician Administered PTSD Scale for DSM-IV(CAPS;
Blake et al. 1995).
4. Participants on psychiatric medication must be on a stable regimen for at least 2
weeks before treatment begins.
5. Veteran eligible for VA services.
6. Ability to participate psychologically and physically, able to give informed consent
and complete assessments, and participate in study procedures.
Exclusion Criteria:
1. Psychotic symptoms as determined by the SCID.
2. Serious current psychiatric symptoms, such as suicidal ideation or homicidal
ideation.
3. Opioid dependence as determined by the SCID.
4. Legal charges pending with potential of incarceration.
5. Unstable, serious medical condition or one requiring acute medical treatments, or
anticipation of hospitalization for extended care. |
|
|
|
| Study is available at: |
|
VA Connecticut Healthcare System - West Haven Campus
West Haven, CT 06516
United States
Primary Contact:
Elissa McCarthy, Ph.D.
Email: elissa.mccarthy@va.gov
Phone: 203-932-5711 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|